- Home
- AMS vs GELS Comparison
AMS vs GELS Comparison
Compare AMS & GELS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMS
- GELS
- Stock Information
- Founded
- AMS 1980
- GELS 2018
- Country
- AMS United States
- GELS Australia
- Employees
- AMS N/A
- GELS N/A
- Industry
- AMS Medical Specialities
- GELS
- Sector
- AMS Health Care
- GELS
- Exchange
- AMS Nasdaq
- GELS NYSE
- Market Cap
- AMS 18.3M
- GELS 15.9M
- IPO Year
- AMS N/A
- GELS 2024
- Fundamental
- Price
- AMS $2.35
- GELS $1.88
- Analyst Decision
- AMS
- GELS
- Analyst Count
- AMS 0
- GELS 0
- Target Price
- AMS N/A
- GELS N/A
- AVG Volume (30 Days)
- AMS 13.6K
- GELS 4.0M
- Earning Date
- AMS 08-13-2025
- GELS 02-15-2025
- Dividend Yield
- AMS N/A
- GELS N/A
- EPS Growth
- AMS 151.01
- GELS N/A
- EPS
- AMS 0.21
- GELS N/A
- Revenue
- AMS $29,236,000.00
- GELS $95,618.00
- Revenue This Year
- AMS $23.63
- GELS N/A
- Revenue Next Year
- AMS N/A
- GELS N/A
- P/E Ratio
- AMS $11.30
- GELS N/A
- Revenue Growth
- AMS 35.25
- GELS N/A
- 52 Week Low
- AMS $2.30
- GELS $0.77
- 52 Week High
- AMS $4.60
- GELS $5.50
- Technical
- Relative Strength Index (RSI)
- AMS 46.47
- GELS N/A
- Support Level
- AMS $2.30
- GELS N/A
- Resistance Level
- AMS $2.50
- GELS N/A
- Average True Range (ATR)
- AMS 0.12
- GELS 0.00
- MACD
- AMS 0.01
- GELS 0.00
- Stochastic Oscillator
- AMS 32.36
- GELS 0.00
About AMS American Shared Hospital Services
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.
About GELS GELTEQ LIMITED
Gelteq Ltd is a clinical and science-based company that is focused on developing and commercializing white-label gel-based delivery solutions to preserve the simplicity, accessibility and efficacy of oral delivery without the impediments traditionally associated with other oral delivery methods, with prescription drugs, nutraceuticals, pet care, and other products. It is engaged in the development and testing of a gel-based delivery system for humans and pets. Its principal products are edible gels.